SOURCE SCIENTIFIC INC
10QSB/A, 1997-02-10
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: FLORIDA GAMING CORP, 8-K/A, 1997-02-10
Next: HARKEN ENERGY CORP, S-3, 1997-02-10




================================================================================

                    U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                               ------------------

                                  Form 10-QSB/A

                               ------------------

          [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934
                For the quarterly period ended September 30, 1996

          [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934

                For the transition period from __________ to __________

                               ------------------

                         Commission file number 1-8311

                            SOURCE SCIENTIFIC, INC.
       (Exact name of small business issuer as specified in its charter)


               California                              95-2943936 
     (State or other jurisdiction                    (I.R.S.  Employer
     of incorporation or organization)               Identification No.)


                7390 Lincoln Way, Garden Grove, California 92841
              (Address of principal executive offices) (Zip Code)

                                 (714)898-9001
                           Issuer's telephone number

                               ------------------

     Check  whether  the issuer (1) filed all  reports  required  to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing  requirements for the past 90 days. Yes X No __.

         APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS
                        DURING THE PRECEDING FIVE YEARS

     Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the  distribution  of
securities  under a plan  confirmed by a court.  Yes No __. 

                      APPLICABLE ONLY TO CORPORATE ISSUERS

     State the number of shares  outstanding of each of the issuer's  classes of
common equity, as of November 12, 1996:  20,236,919  

     Transitional  Small  Business Disclosure Format (Check one): Yes __ No X .

================================================================================
<PAGE>



                                   SIGNATURES

In accordance with the  requirements of the Exchange Act, the registrant  caused
this  Report  to be  signed  on its  behalf  by the  undersigned,  thereto  duly
authorized.

                                         SOURCE SCIENTIFIC, INC.

                                      By:  /S/ RICHARD A. SULLIVAN
Date: 02-07-97                             Richard A. Sullivan
                                           President and Chief Executive Officer


                                      By:  /S/ MOKHTAR A. SHAWKY
Date: 02-07-97                             Mokhtar A. Shawky
                                           Chief Financial Officer


<PAGE>

PART II - - OTHER INFORMATION

ITEM 6.   EXHIBITS AND REPORTS ON FORM 8-K.

     (a)  Exhibits:

          *27.0   Financial Data Schedule (included with EDGAR electronic filing
                  of this report with the Securities and Exchange Commission.)



<TABLE> <S> <C>

<ARTICLE>                     5
<MULTIPLIER>                  1,000
       
<S>                                    <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                      JUN-30-1997
<PERIOD-START>                         JUL-01-1996
<PERIOD-END>                           SEP-30-1996
<CASH>                                          78
<SECURITIES>                                     0
<RECEIVABLES>                                  490
<ALLOWANCES>                                   (13)
<INVENTORY>                                  1,079
<CURRENT-ASSETS>                             1,810
<PP&E>                                         340
<DEPRECIATION>                                (275)
<TOTAL-ASSETS>                               1,986
<CURRENT-LIABILITIES>                          785
<BONDS>                                          0
                            0
                                      0
<COMMON>                                    20,757
<OTHER-SE>                                  (2,215)
<TOTAL-LIABILITY-AND-EQUITY>                 1,986  
<SALES>                                      1,123
<TOTAL-REVENUES>                             1,123
<CGS>                                          837
<TOTAL-COSTS>                                  837
<OTHER-EXPENSES>                               501
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                              11
<INCOME-PRETAX>                               (226)
<INCOME-TAX>                                     0
<INCOME-CONTINUING>                           (226)
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                                  (226)
<EPS-PRIMARY>                               (0.011)
<EPS-DILUTED>                               (0.006)

        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission